Cargando…

Development of activated endothelial targeted high-density lipoprotein nanoparticles

Endothelial inflammation is an important pathophysiological driving force in various acute and chronic inflammatory diseases. High-density lipoproteins (HDLs) play critical roles in regulating endothelial functions and resolving endothelial inflammation. In the present study, we developed synthetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Minzhi, Hong, Kristen, Adili, Reheman, Mei, Ling, Liu, Lisha, He, Hongliang, Guo, Yanhong, Chen, Y. Eugene, Holinstat, Michael, Schwendeman, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464908/ https://www.ncbi.nlm.nih.gov/pubmed/36105190 http://dx.doi.org/10.3389/fphar.2022.902269

Ejemplares similares

Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice
por: He, Hongliang, et al.
Publicado: (2020)

Evaluation of receptor‐ligand mechanisms of dual‐targeted particles to an inflamed endothelium
por: Fromen, Catherine A., et al.
Publicado: (2016)

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
por: Morin, Emily E., et al.
Publicado: (2020)

Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines
por: Duan, Huxinyue, et al.
Publicado: (2023)

Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
por: Guo, Yanhong, et al.
Publicado: (2017)

Deformable microparticles for shuttling nanoparticles to the vascular wall
por: Fish, Margaret B., et al.
Publicado: (2021)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
por: Xu, Wenqi, et al.
Publicado: (2019)

Effect of Lipid Composition on the Atheroprotective Properties of HDL-Mimicking Micelles
por: Hong, Kristen, et al.
Publicado: (2022)

Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice
por: Adili, Reheman, et al.
Publicado: (2021)

The Role of High-Density Lipoprotein in COVID-19
por: Wang, Guyi, et al.
Publicado: (2021)

Paeonol Inhibits Oxidized Low-Density Lipoprotein-Induced Vascular Endothelial Cells Autophagy by Upregulating the Expression of miRNA-30a
por: Li, Chao, et al.
Publicado: (2018)

Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma
por: Kuai, Rui, et al.
Publicado: (2017)

Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
por: Duan, Xin, et al.
Publicado: (2021)

lncRNA ZEB1-AS1 Mediates Oxidative Low-Density Lipoprotein-Mediated Endothelial Cells Injury by Post-transcriptional Stabilization of NOD2
por: Xu, Xiaohui, et al.
Publicado: (2019)

Structural Insights into High Density Lipoprotein: Old Models and New Facts
por: Gogonea, Valentin
Publicado: (2016)

Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
por: Yuan, Yue, et al.
Publicado: (2016)

High-density lipoproteins during sepsis: from bench to bedside
por: Tanaka, Sébastien, et al.
Publicado: (2020)

Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases
por: Schultz, Mark L., et al.
Publicado: (2019)

Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation
por: Luo, Yonghong, et al.
Publicado: (2021)

HDL in sepsis – risk factor and therapeutic approach
por: Morin, Emily E., et al.
Publicado: (2015)

Eicosanoids in inflammation in the blood and the vessel
por: Yamaguchi, Adriana, et al.
Publicado: (2022)

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
por: Gordon, Elizabeth M., et al.
Publicado: (2016)

The emerging role of oxylipins in thrombosis and diabetes
por: Tourdot, Benjamin E., et al.
Publicado: (2014)

Monocyte to high-density lipoprotein and apolipoprotein A1 ratios are associated with bone homeostasis imbalance caused by chronic inflammation in postmenopausal women with type 2 diabetes mellitus
por: Huang, Rong, et al.
Publicado: (2022)

N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors
por: Zhang, Chun-ge, et al.
Publicado: (2014)

Anticipatory Role of High Density Lipoprotein and Endothelial Dysfunction: An Overview
por: Eren, Esin, et al.
Publicado: (2014)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Elucidation of physico-chemical principles of high-density lipoprotein–small RNA binding interactions
por: Michell, Danielle L., et al.
Publicado: (2022)

L-cystathionine protects against oxidative stress and DNA damage induced by oxidized low-density lipoprotein in THP-1-derived macrophages
por: Peng, Hanlin, et al.
Publicado: (2023)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

GPR56/ADGRG1 is a platelet collagen-responsive GPCR and hemostatic sensor of shear force
por: Yeung, Jennifer, et al.
Publicado: (2020)

Human Endothelial Progenitor Cells Internalize High-Density Lipoprotein
por: Srisen, Kaemisa, et al.
Publicado: (2013)

Endothelial lipase increases antioxidative capacity of high-density lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2019)

Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma
por: Scheetz, Lindsay M., et al.
Publicado: (2020)

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
por: Alghamri, Mahmoud S., et al.
Publicado: (2021)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
por: Kornmueller, Karin, et al.
Publicado: (2019)

High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma
por: Kudinov, Vasily A., et al.
Publicado: (2020)

The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial
por: Liao, Jianwei, et al.
Publicado: (2022)

Cargo-free particles divert neutrophil-platelet aggregates to reduce thromboinflammation
por: Banka, Alison L., et al.
Publicado: (2023)

Targeting Lymphatics for Nanoparticle Drug Delivery
por: McCright, Jacob, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmvjfcis0fe7f0cda67snovqcv